Accredo To Pay $60M In Novartis Exjade Kickback Suit
Specialty pharmacy Accredo Health Group Inc. will pay $14.9 million to resolve state regulators' claims it participated in a patient referral kickback scheme with Novartis Pharmaceutical Corp., U.S. Attorney Preet Bharara...To view the full article, register now.
Already a subscriber? Click here to view full article